TOP TIERMARKET NEWSWIRE

News & sentiment

IMMUNIC INC (IMUX) — News & AI sentiment

IMMUNIC INC (IMUX) news roundup. 8 stories in the past week, 16 over 30 days. Average 30-day sentiment is 57.1/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

8

avg sentiment 54.6/100

30d stories

16

avg sentiment 57.1/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

IMUX news in the last 24 hours, 7 days, 30 days and 90 days

How much IMUX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	IMUX stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	8	54.6/100	IMUX headlines →
Last 30 days	16	57.1/100	IMUX headlines →
Last 90 days	33	54.8/100	IMUX headlines →

Latest stories on IMUX

IMMUNIC, INC. (IMUX) files 8-K

SEC 8-K50 · neutralgeneral

2d ago

Immunic, Inc. (IMUX) Discusses R&D Advances and Future Directions in Relapsing Multiple Sclerosis Transcript

Seeking Alpha63 · neutralproduct/pr

2d ago

Immunic, Inc. (IMUX) Presents at EFMC Medicinal Chemistry 2026 Basel - Slideshow

Seeking Alpha50 · neutralproduct/pr

3d ago

Stifel reiterates Immunic stock rating on MS drug potential

Investing.com Analyst Ratings56 · neutralanalyst

3d ago

H.C. Wainwright reiterates Immunic stock rating on MS drug progress

Investing.com Analyst Ratings56 · neutralanalyst

3d ago

Immunic, Inc. (IMUX) Discusses R&D Advances and Future Directions in Relapsing Multiple Sclerosis - Slideshow

Seeking Alpha56 · neutralproduct/pr

4d ago

Immunic Highlights Multiple Sclerosis Program in R&D Webinar

TipRanks56 · neutralproduct/pr

4d ago

IMMUNIC, INC. (IMUX) files 8-K

SEC 8-K50 · neutralgeneral

4d ago

Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026

PR Newswire56 · neutralproduct/pr

Sep 2

Immunic appoints Chitrang Davé as chief data and digital officer

Yahoo Top56 · neutralgeneral

Sep 1

Immunic appoints Chitrang Dave as chief data, digital officer

The Fly56 · neutralgeneral

Sep 1

Immunic price target raised to $29 from $19 at Roth Capital

The Fly63 · neutralanalyst

Sep 1

Immunic Appoints Chitrang Davé as Chief Data and Digital Officer

PR Newswire56 · neutralgeneral

Sep 1

Immunic: Potent Under-The-Radar MS Lineup Set For A Rerating

Seeking Alpha67 · bullishproduct/pr

Aug 25

Wedbush initiates Immunic stock with Outperform rating

Investing.com Analyst Ratings61 · neutralanalyst

Aug 17

Immunic initiated with an Outperform at Wedbush

The Fly61 · neutralanalyst

Aug 17

Immunic advances MS drug toward key Phase 3 data, expects results by year-end

Yahoo Finance67 · bullishproduct/pr

Aug 11

Immunic Adds Veteran Finance Leader to Board

TipRanks56 · neutralgeneral

Aug 11

IMMUNIC, INC. (IMUX) files 8-K

SEC 8-K50 · neutralgeneral

Aug 11

Immunic reports Q2 EPS (80c), consensus ($1.16)

The Fly28 · bearishearnings

Aug 11

Immunic GAAP EPS of -$0.80 beats by $0.37

Seeking Alpha56 · neutralearnings

Aug 11

EQS-News: Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Business Insider50 · neutralearnings

Aug 11

Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update

PR Newswire50 · neutralgeneral

Aug 11

Immunic appoints Elena Ridloff to board of directors

Yahoo Top59 · neutralgeneral

Aug 10

Immunic Appoints Elena Ridloff to Board of Directors

PR Newswire56 · neutralgeneral

Aug 10

Open IMUX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →